VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells

Growth Factors

Volumn 28, Issue 5, 2010, Pages 306-317

  Cui, Fuai ^a,b   Wang, Xiuli ^b   Liu, Xianxi ^a   Dighe, Abhijit S ^b   Balian, Gary ^b   Cui, Quanjun ^a,b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiogenesis; Bone morphogenetic protein 6; Osteogenesis; Vascular endothelial growth factor

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 6; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE TRANSPLANTATION; CELL CULTURE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL; TUMOR SEEDING;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 6; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELLS; MICE; OSTEOCALCIN; OSTEOGENESIS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957757820     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2010.484423     Document Type: Article

References (44)

1. Attal J, Theron MC, Houdebine LM. 1999. The optimal use of IRES (internal ribosome entry site) in expression vectors. Genet Anal 15:161-165.
2. Botchwey EA, Pollack SR, Levine EM, Laurencin CT. 2001. Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J Biomed Mater Res 55:242-253.
3. Botchwey EA, Dupree MA, Pollack SR, Levine EM, Laurencin CT. 2003. Tissue engineered bone: Measurement of nutrient transport in three-dimensional matrices. J Biomed Mater Res A 67:357-367.
4. Cui Q, Xiao Z, Li X, Saleh KJ, Balian G. 2006. Use ofgenetically engineered bone-marrow stem cells to treat femoral defects: An experimental study. J Bone Joint Surg Am 88(Suppl 3): 167-172.
5. Desmyter S, Goubau Y, Benahmed N, de Wever A, Verdonk R. 2008. The role of bone morphogenetic protein-7 (Osteogenic Protein-1) in the treatment of tibial fracture non-unions. An overview of the use in Belgium. Acta Orthop Belg 74:534-537.
6. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. 2005. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4): S51-S59.
7. Dohin B, Dahan-Oliel N, Fassier F, Hamdy R. 2009. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): Early experience. Clin Orthop Relat Res 467: 3230-3238.
8. Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I. 2005. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87:1434-1438. (Pubitemid 41511813)
9. Fiedler J, Roderer G, Gunther KP, Brenner RE. 2002. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-312.
10. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE. 2005. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334:561-568.
11. Friedman MS, Long MW, Hankenson KD. 2006. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98:538-554.
12. Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W. 2005. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20:2028-2035.
13. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
14. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T, BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123-2134.
15. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. 2001. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 81:284-294.
16. Hansen-Algenstaedt N, Joscheck C, Wolfram L, Schaefer C, Muller I, Bottcher A, Deuretzbacher G, Wiesner L, Leunig M, Algenstaedt P, Ruther W 2006. Sequential changes in vessel formation and micro-vascular function during bone repair. Acta Orthop 77:429-439.
17. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. 2005. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20:848-857.
18. Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel AJ, Deng M, Lv Q, Nair LS, Doty SB, Laurencin CT. 2008. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA 105:11099-11104.
19. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. 1988. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636-2643.
20. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH. 2006. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21:735-744.
21. Kanczler JM, Ginty PJ, Barry JJ, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. 2008. The effect ofmesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 29:1892-1900.
22. Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. 2010. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31:1242-1250.
23. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC. 2004. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11:1312-1320.
24. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. 2009. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30:2816-2825.
25. Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA. 2003. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10:1735-1743.
26. Martinez-Salas E. 1999. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol 10:458-464.
27. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE. 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472-477.
28. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22.
29. Newman KD, Mc Burney MW. 2004. Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripo-tent stem cells. Biomaterials 25:5763-5771.
30. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y 2007. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 354:453-458.
31. Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325.
32. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. 2002. Synergistic enhancement ofbone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751-759.
33. Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J. 2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation ofangiogenesis. J Bone Miner Res 20:2017-2027.
34. Probst A, Spiegel HU. 1997. Cellular mechanisms ofbone repair. J Invest Surg 10:77-86.
35. Pufe T, Petersen W, Tillmann B, Mentlein R. 2001. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44:1082-1088. (Pubitemid 32433613)
36. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. 2008. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108:18-31.
37. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P. 2007. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell prolifer-ation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972.
38. Street J, Lenehan B. 2009. Vascular endothelial growth factor regulates osteoblast survival-evidence for an autocrine feedback mechanism. J Orthop Surg Res 4:19.
39. Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661.
40. Tatsuyama K, Maezawa Y, Baba H, Imamura Y, Fukuda M. 2000. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 44:269-278.
41. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T 2003. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32:491-501.
42. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE. 2002. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395:110-120.
43. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, La Pan P. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224.
44. Zelzer E, Mc Lean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR. 2002. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893-1904.